12:00 AM
 | 
Jul 24, 2000
 |  BC Week In Review  |  Company News  |  Deals

MedImmune Inc., SmithKline deal

SBH received from MEDI worldwide exclusive rights to develop and commercialize a Streptococcus pneumoniae vaccine that is in preclinical evaluation. MEDI could receive $30...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >